| Name | Title | Contact Details |
|---|
As a top exporter of premium pork products worldwide, Triumph Foods has positioned itself as one of the leading pork processors in the United States. The Company, which began operations of its pork processing plant in January 2006 in St. Joseph, Missouri, is producer owned. The state-of-the-art facility, 6.1 million hogs each year, is the newest such facility in the United States. Featuring the latest food quality and safety innovations and improvements the Company prides itself on producing only the highest quality pork products found in the market today.
Richelieu Foods, Inc. is one of the leading companies in the Manufacturing sector.
Founded more than 80 years ago, OK Foods has evolved from a livestock and poultry feed manufacturer to one of the world`s largest fully-integrated chicken producers. In November 2011, OK Foods was integrated into Industrias Bachoco located in Celaya, Mexico. Today, the OK Foods family includes more than 3,000 team members who are dedicated to producing consistently high-quality chicken products and nourishing people around the world.
Tate & Lyle`s purpose, Improving Lives for Generations, inspires everything we do. Whether it`s by making food and drink healthier and tastier; continuously improving how we work; promoting a safe working environment; or making a difference to our local communities, we believe we can successfully grow our business and have a positive impact on society.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.